Spring Boost is an alcohol-infused rosemary tincture. The manufacturer positions it for circulatory support, particularly for customers concerned about poor circulation. This is the product’s intended positioning; it is not evidence that the finished tincture treats circulatory disease or produces a clinically established improvement in blood flow.
Directions
Take 20 drops in water twice daily, as confirmed by the manufacturer.
What the evidence does and does not show
European traditional-use information for rosemary leaf distinguishes preparations and routes: its traditional peripheral-circulation use is a bath preparation, while oral rosemary leaf tea is addressed for mild digestive symptoms. Neither use establishes a circulatory effect for this alcohol-infused tincture. A small prospective study of a specified oral rosemary extract in healthy young volunteers examined a different preparation; it does not demonstrate that Spring Boost improves blood flow or treats poor circulation.
The manufacturer confirms an alcohol infusion, but the available product record does not state the rosemary plant part, tincture strength or finished-product alcohol percentage. Ask the seller or manufacturer if those details matter to you.
Frequently Asked Questions
What is Spring Boost?
A rosemary tincture prepared through alcohol infusion and intended by the manufacturer for circulatory support.
How do I take it?
Take 20 drops in water twice daily.
Is improved blood flow clinically established for this tincture?
No. Traditional information and research on other rosemary preparations do not establish an effect for this finished tincture.
What should I keep in mind?
Circulatory symptoms require appropriate healthcare assessment. Seek individual professional advice if you take medicines or have a health condition. The finished-product alcohol percentage is not stated in the available record.
European Medicines Agency: rosemary leaf overview. Study of a specified oral rosemary extract in healthy volunteers.


Reviews
There are no reviews yet.